Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

STRATA Skin Sciences (SSKN) Research & Development (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Research & Development for 14 consecutive years, with $67000.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 66.5% to $67000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $421000.0 through Dec 2025, down 52.32% year-over-year, with the annual reading at $421000.0 for FY2025, 52.32% down from the prior year.
  • Research & Development hit $67000.0 in Q4 2025 for STRATA Skin Sciences, down from $172000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $441000.0 in Q4 2022 to a low of $67000.0 in Q4 2025.
  • Historically, Research & Development has averaged $254200.0 across 5 years, with a median of $242000.0 in 2024.
  • Biggest five-year swings in Research & Development: soared 93.25% in 2023 and later plummeted 66.5% in 2025.
  • Year by year, Research & Development stood at $276000.0 in 2021, then soared by 59.78% to $441000.0 in 2022, then fell by 13.83% to $380000.0 in 2023, then plummeted by 47.37% to $200000.0 in 2024, then tumbled by 66.5% to $67000.0 in 2025.
  • Business Quant data shows Research & Development for SSKN at $67000.0 in Q4 2025, $172000.0 in Q3 2025, and $86000.0 in Q2 2025.